Meyerovitch J, Backer J M, Kahn C R
Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215.
J Clin Invest. 1989 Sep;84(3):976-83. doi: 10.1172/JCI114261.
Phosphotyrosine phosphatase (PTPase) activity in rat liver was measured using a phosphopeptide substrate containing sequence identity to the major site of insulin receptor autophosphorylation. PTPase activity was detected in both cytosolic and particulate fractions of rat liver and produced linear dephosphorylation over a 15-min time course. In rats made insulin-deficient diabetic by streptozotocin treatment (STZ), cytosolic PTPase activity increased to 180% of the control values after 2 d of diabetes and remained elevated at 30 d (P less than 0.02). Gel filtration on Sephadex-75 revealed a single peak of activity in the cytosol in both control and diabetic animals and confirmed the increased levels. In BB diabetic rats, another model of insulin deficiency, the PTPase activity in the cytosolic fraction was increased to approximately 230% of control values. PTPase activity in the particulate fraction of liver was also increased by 30 and 80% after 2 and 8 d of STZ diabetes, respectively. However, this increase was not sustained and after 30 d of STZ diabetes, PTPase activity associated with the particulate fraction in the BB diabetic rat was reduced to approximately 70% of the control levels. Treatment of STZ diabetic rats with subcutaneous insulin or vanadate in their drinking water for 3 d reduced tyrosine PTPase activity in the particulate, but not in the cytosolic fraction. This was associated with a change in blood glucose toward normal. These data indicate insulin deficient diabetes is accompanied by significant changes in hepatic PTPase activity. Since tyrosine phosphorylation plays a central role in the cellular action of insulin receptor, an increase in PTPase activity may be an important factor in the altered insulin action associated with these diabetic states.
使用一种与胰岛素受体自身磷酸化主要位点具有序列同一性的磷酸肽底物来测定大鼠肝脏中的磷酸酪氨酸磷酸酶(PTPase)活性。在大鼠肝脏的胞质和微粒体部分均检测到PTPase活性,并且在15分钟的时间进程中产生线性去磷酸化。通过链脲佐菌素处理(STZ)使大鼠成为胰岛素缺乏型糖尿病模型,糖尿病2天后,胞质PTPase活性增加至对照值的180%,并在30天时仍保持升高(P<0.02)。在Sephadex - 75上进行凝胶过滤显示,对照动物和糖尿病动物的胞质中均有一个单一的活性峰,并证实了活性水平的升高。在另一种胰岛素缺乏模型——BB糖尿病大鼠中,胞质部分的PTPase活性增加至对照值的约230%。STZ糖尿病2天和8天后,肝脏微粒体部分的PTPase活性也分别增加了30%和80%。然而,这种增加并未持续,STZ糖尿病30天后,BB糖尿病大鼠微粒体部分相关的PTPase活性降至对照水平的约70%。给STZ糖尿病大鼠皮下注射胰岛素或在饮水中加入钒酸盐处理3天,可降低微粒体部分的酪氨酸PTPase活性,但对胞质部分无影响。这与血糖向正常水平的变化相关。这些数据表明,胰岛素缺乏型糖尿病伴随着肝脏PTPase活性的显著变化。由于酪氨酸磷酸化在胰岛素受体的细胞作用中起核心作用,PTPase活性的增加可能是与这些糖尿病状态相关的胰岛素作用改变的一个重要因素。